We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension.
- Authors
Alves Marques, Lais; da Silva Souza, Cristina; Leite Souto Viana, Lorrany Mayandra; Batista Oliveira, Izabel Luiza; Silva Santos, Yane; da Silva Araújo, Tiago Ferreira; da Silva, Daniel Tenório
- Abstract
Systemic Arterial Hypertension (SAH) is a multifactorial clinical condition with nonpharmacological and/or pharmacological treatment that requires pharmacotherapeutic monitoring in order to manage the health condition. The objective was to evaluate the impact of a pharmacotherapeutic follow-up program of patients with SAH through a quasi-experimental, longitudinal, and prospective study. Twenty-eight patients were evaluated, 50% of which had decompensated blood pressure; the DRPs identified were drug interactions (57.1%), pharmacotherapeutic duplication (28.8%), potentially inappropriate medication use in older adults (38.5%), and non-adherence to treatment (89.3%). Of the NOM identified (Negative Outcomes associated with Medication), 56.2% were related to safety, and 37.5% to effectiveness. After the follow-up, 56.3% of the NOM were resolved, 57.1% of patients adhered to treatment, and there was a reduction in the Systolic Blood Pressure (p = 0.010) and Diastolic Blood Pressure (p = 0.020). The program proved to be efficient in reducing systemic blood pressure and resolving DRPs and NOM.
- Subjects
DRUG therapy; HYPERTENSION; CLINICAL trials
- Publication
Saúde e Pesquisa, 2021, Vol 14, p84
- ISSN
1983-1870
- Publication type
Article
- DOI
10.17765/2176-9206.2021v14Supl.1.e9133